Intratumoral heterogeneity and drug response in high-grade serous carcinoma

被引:0
|
作者
Brenton, James D. [1 ]
机构
[1] Univ Cambridge, Cambridge, Cambs, England
关键词
D O I
10.1158/1078-0432.OVCA13-IA19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA19
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma
    Singh, Priya
    Kaushal, Vikrant
    Rai, Bhavana
    Rajwanshi, Arvind
    Gupta, Nalini
    Dey, Pranab
    Garg, Rashi
    Rohilla, Manish
    Suri, Vanita
    Ghoshal, Sushmita
    Srinivasan, Radhika
    HISTOPATHOLOGY, 2018, 72 (04) : 619 - 625
  • [32] New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients
    Torkildsen, Cecilie Fredvik
    Austdal, Marie
    Jarmund, Anders Hagen
    Kleinmanns, Katrin
    Lamark, Eva Karin
    Nilsen, Elisabeth Berge
    Stefansson, Ingunn
    Sande, Ragnar Kvie
    Iversen, Ann-Charlotte
    Thomsen, Liv Cecilie Vestrheim
    Bjorge, Line
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Ibrahim Yalcin
    Hanifi Sahin
    Mustafa Erkan Sari
    Asuman Nihan Haberal
    Eda Adeviye Sahin
    Husnu Celik
    Mehmet Mutlu Meydanli
    Ali Ayhan
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [34] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Yalcin, Ibrahim
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Haberal, Asuman Nihan
    Sahin, Eda Adeviye
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [35] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [36] Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma
    Chen, Hui
    Gotimer, Kristin
    De Souza, Cristabelle
    Tepper, Clifford G.
    Karnezis, Anthony N.
    Leiserowitz, Gary S.
    Chien, Jeremy
    Smith, Lloyd H.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (03) : 783 - 792
  • [37] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [38] Single cell multiomic profiling of high-grade serous carcinoma
    Sandoval, Leticia Assad Maia
    Ismail, Wazim Mohammed
    Mazzone, Amelia
    Munankarmy, Amik
    Kaur, Jagneet
    Tashi, Tsering
    Hou, Xiaonan
    Kannan, Nagarajan
    Oberg, Ann
    Kaufmann, Scott H.
    Weroha, Saravut John
    Gaspar-Maia, Alexandre
    CANCER RESEARCH, 2023, 83 (07)
  • [39] HMGA2 and high-grade serous ovarian carcinoma
    Jingjing Wu
    Jian-Jun Wei
    Journal of Molecular Medicine, 2013, 91 : 1155 - 1165
  • [40] Platinum Resistance in High-Grade Serous Ovarian Cancer: an Intratumoral Collagen Fiber Implication
    Pavanello, Marina
    Natal, Rodrigo de Andrade
    Ramalho, Susana
    Vassallo, Jose
    de Angelo Andrade, Liliana Aparecida
    Derchain, Sophie
    Sarian, Luis Otavio
    FASEB JOURNAL, 2016, 30